Calculation
P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenues1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 15, 2024 | 11.16 | = | 426.29 | ÷ | 38.21 | 38.21 | = | 9,869,200 | ÷ | 258,307,816 | |
Feb 10, 2023 | 8.56 | = | 297.40 | ÷ | 34.74 | 34.74 | = | 8,930,700 | ÷ | 257,091,441 | |
Feb 9, 2022 | 8.21 | = | 244.24 | ÷ | 29.75 | 29.75 | = | 7,574,400 | ÷ | 254,576,691 | |
Feb 11, 2021 | 8.82 | = | 210.50 | ÷ | 23.87 | 23.87 | = | 6,205,683 | ÷ | 259,960,062 | |
Feb 13, 2020 | 14.95 | = | 240.09 | ÷ | 16.06 | 16.06 | = | 4,162,821 | ÷ | 259,268,593 | |
Feb 13, 2019 | 15.54 | = | 185.25 | ÷ | 11.92 | 11.92 | = | 3,047,597 | ÷ | 255,656,889 | |
Feb 15, 2018 | 16.42 | = | 160.94 | ÷ | 9.80 | 9.80 | = | 2,488,652 | ÷ | 253,891,984 | |
Feb 23, 2017 | 12.51 | = | 85.73 | ÷ | 6.85 | 6.85 | = | 1,702,177 | ÷ | 248,438,127 | |
Feb 16, 2016 | 20.38 | = | 85.37 | ÷ | 4.19 | 4.19 | = | 1,032,336 | ÷ | 246,391,955 | |
Feb 13, 2015 | 47.41 | = | 113.66 | ÷ | 2.40 | 2.40 | = | 580,415 | ÷ | 242,088,884 | |
Feb 11, 2014 | 16.53 | = | 84.98 | ÷ | 5.14 | 5.14 | = | 1,211,975 | ÷ | 235,771,942 | |
Mar 1, 2013 | 6.60 | = | 46.17 | ÷ | 7.00 | 7.00 | = | 1,527,042 | ÷ | 218,188,628 | |
Feb 22, 2012 | 5.61 | = | 37.60 | ÷ | 6.71 | 6.71 | = | 1,410,626 | ÷ | 210,335,993 | |
Feb 17, 2011 | 56.82 | = | 39.85 | ÷ | 0.70 | 0.70 | = | 143,370 | ÷ | 204,412,712 | |
Feb 19, 2010 | 80.12 | = | 40.70 | ÷ | 0.51 | 0.51 | = | 101,889 | ÷ | 200,576,408 | |
Feb 17, 2009 | 28.70 | = | 33.10 | ÷ | 1.15 | 1.15 | = | 175,504 | ÷ | 152,189,782 | |
Feb 11, 2008 | 12.17 | = | 18.21 | ÷ | 1.50 | 1.50 | = | 199,012 | ÷ | 132,964,533 | |
Mar 1, 2007 | 17.58 | = | 30.03 | ÷ | 1.71 | 1.71 | = | 216,356 | ÷ | 126,650,456 | |
Mar 16, 2006 | 26.93 | = | 39.49 | ÷ | 1.47 | 1.47 | = | 160,890 | ÷ | 109,734,852 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Vertex Pharmaceuticals Inc. Annual Report.
Comparison to Competitors
Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb 15, 2024 | 11.16 | 5.72 | 5.78 | 2.19 | 7.76 | 20.77 | 3.40 | 4.43 | 5.43 | 2.66 | 7.84 | 4.99 |
Feb 10, 2023 | 8.56 | 4.61 | 5.17 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 4.71 | 2.37 | 7.01 | 4.73 |
Feb 9, 2022 | 8.21 | 4.53 | 5.10 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.96 | 3.18 | 4.20 | 5.39 |
Feb 11, 2021 | 8.82 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 4.50 | 6.24 | 5.52 |
Feb 13, 2020 | 14.95 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | 3.66 | 5.34 | 4.83 |
Feb 13, 2019 | 15.54 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | 4.49 | 6.62 | 4.24 |
Feb 15, 2018 | 16.42 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | 4.05 | 5.92 | 4.01 |
Feb 23, 2017 | 12.51 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | 3.84 | 7.86 | 3.37 |
Feb 16, 2016 | 20.38 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | 3.76 | 9.38 | 3.05 |
Feb 13, 2015 | 47.41 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | 4.24 | 14.62 | 3.06 |
Feb 11, 2014 | 16.53 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | 3.97 | 15.52 | 3.74 |
Mar 1, 2013 | 6.60 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | 3.34 | 11.66 | 2.12 |
Feb 22, 2012 | 5.61 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | 2.37 | 20.90 | 1.77 |
Feb 17, 2011 | 56.82 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | 2.27 | 7.38 | 2.00 |
Feb 19, 2010 | 80.12 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | 2.83 | 5.74 | 1.98 |
Feb 17, 2009 | 28.70 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | 1.72 | 5.17 | 1.44 |
Feb 11, 2008 | 12.17 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | 3.11 | 11.94 | 2.40 |
Mar 1, 2007 | 17.58 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | 3.67 | 19.70 | 5.05 |
Mar 16, 2006 | 26.93 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | 3.77 | 14.06 | 2.15 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Vertex Pharmaceuticals Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Vertex Pharmaceuticals Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Feb 15, 2024 | 11.16 | 5.90 |
Feb 10, 2023 | 8.56 | 4.57 |
Feb 9, 2022 | 8.21 | 4.51 |
Feb 11, 2021 | 8.82 | 4.91 |
Feb 13, 2020 | 14.95 | 4.88 |
Feb 13, 2019 | 15.54 | 4.54 |
Feb 15, 2018 | 16.42 | 4.60 |
Feb 23, 2017 | 12.51 | 4.29 |
Feb 16, 2016 | 20.38 | 4.10 |
Feb 13, 2015 | 47.41 | 4.54 |
Feb 11, 2014 | 16.53 | 4.30 |
Mar 1, 2013 | 6.60 | 3.25 |
Feb 22, 2012 | 5.61 | 2.58 |
Feb 17, 2011 | 56.82 | 2.44 |
Feb 19, 2010 | 80.12 | 3.00 |
Feb 17, 2009 | 28.70 | 2.22 |
Feb 11, 2008 | 12.17 | 3.19 |
Mar 1, 2007 | 17.58 | 3.88 |
Mar 16, 2006 | 26.93 | 3.84 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Vertex Pharmaceuticals Inc. | Health Care | |
---|---|---|
Feb 15, 2024 | 11.16 | 2.46 |
Feb 10, 2023 | 8.56 | 35,311.43 |
Feb 9, 2022 | 8.21 | 2.39 |
Feb 11, 2021 | 8.82 | 2.33 |
Feb 13, 2020 | 14.95 | 2.24 |
Feb 13, 2019 | 15.54 | 2.45 |
Feb 15, 2018 | 16.42 | 2.43 |
Feb 23, 2017 | 12.51 | 2.24 |
Feb 16, 2016 | 20.38 | 2.23 |
Feb 13, 2015 | 47.41 | 2.54 |
Feb 11, 2014 | 16.53 | 2.31 |
Mar 1, 2013 | 6.60 | 1.82 |
Feb 22, 2012 | 5.61 | 1.63 |
Feb 17, 2011 | 56.82 | 1.54 |
Feb 19, 2010 | 80.12 | 1.73 |
Feb 17, 2009 | 28.70 | 1.43 |
Feb 11, 2008 | 12.17 | 2.09 |
Mar 1, 2007 | 17.58 | 2.53 |
Mar 16, 2006 | 26.93 | 2.82 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).